Blueprint Medicines Corporation (BPMC) Gained 6.35% or 4.95 To Price $82.93 On Wednesday

Blueprint Medicines Corporation (BPMC) gained 6.35% or 4.95 to $82.93. It is around 481408 shares traded, which is 150.87% compare to the average total volume 319094. The market cap of BPMC is $3.60 billion. The year to date change is -2.54%. The 52 week price range is from $32.43 to $92.0. Price of BPMC have changed -0.73% during last week. It have changed 6.41% over last month, 12.93% over last 3 months, 70.26% over last 6 months and 127.28% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BPMC is 77.33. It is -6.75% below current price. The 200-day Moving Averages for BPMC is 59.64. It is -28.08% below current price. The 52-week High is 92.0. It is 10.94% from the current price. The 52-week Low is 32.43. It is -60.89% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BPMC is 7.59 on 2018-01-31. Short % to float is 5.61%. There are some statistics of BPMC. It is has market cap $3.60 billion. The share outstanding is 43.46 million. The average volume is 319094. The revenue is 27.49M. It has 1.23B cash and 33.30M in debt. The percent of top 15 Institution holding is 90.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BPMC is -54.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BPMC is -40.94%.


Share this post